MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid Development for the U.S. Army
MediWound Awarded $6.7 Million to Advance NexoBrid as a Non-Surgical Field Care Solution; R&D Budget Increased to $14.4 MillionMediWound, a leading biopharmaceutical company specializing in innovative wound healing solu...
Dec 28, 2023
Financing Agreement
